publication venue for
- HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds. 2016
- Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.. 20. 2023
- Longitudinal within-host evolution of HIV Nef-mediated CD4, HLA and SERINC5 downregulation activity: a case study.. 17. 2020
- HIV latency reversing agents act through Tat post translational modifications.. 15. 2018
- Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys.. 15. 2018
- Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.. 14. 2017
- HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.. 13. 2016
- Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity.. 12. 2015
- Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.. 11. 2014
- A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function.. 11. 2014
- Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits.. 11. 2014
- Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies.. 11. 2014
- Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.. 11. 2014
- CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.. 10. 2013
- Expression profile of host restriction factors in HIV-1 elite controllers.. 10. 2013
- HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity.. 10. 2013
- Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.. 10. 2013
- LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription.. 10. 2013
- Postnatally-transmitted HIV-1 Envelope variants have similar neutralization-sensitivity and function to that of nontransmitted breast milk variants.. 10. 2013
- Application of a case-control study design to investigate genotypic signatures of HIV-1 transmission.. 9. 2012
- A stabilized HIV-1 envelope glycoprotein trimer fused to CD40 ligand targets and activates dendritic cells.. 8. 2011
- Local replication of simian immunodeficiency virus in the breast milk compartment of chronically-infected, lactating rhesus monkeys.. 7. 2010
- Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.. 3. 2006
- Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41.. 1. 2004
- Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies. 2018
- Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines. 2012